Brady Stephen R's Form 4 filing
Tempest Therapeutics, Inc. (TPST) · filed Jul 8, 2024
- Accession no.
- 0001415889-24-019339
- Filed
- Jul 8, 2024
- Trade date
- Jul 3, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $73.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brady Stephen RCIK 0001606241 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +35,000 | $2.11 | +$73,850 | 46,376 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.